[HTML][HTML] The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review

E Aaldijk, Y Vermeiren - Ageing Research Reviews, 2022 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia, accounting for more than
50 million patients worldwide. Current evidence suggests the exact mechanism behind this …

Serotonergic system, cognition, and BPSD in Alzheimer's disease

S Chakraborty, JC Lennon, SA Malkaram, Y Zeng… - Neuroscience …, 2019 - Elsevier
Abstract Behavioral and Psychological Symptoms of Dementia (BPSD), present in almost
90% of patients with Alzheimer's Disease (AD), cause extensive impairment leading to …

Role of 5-HT7 receptors in the immune system in health and disease

A Quintero-Villegas, SI Valdés-Ferrer - Molecular Medicine, 2020 - Springer
Abstract In mammalians, serotonin (5-HT) has critical roles in the central nervous system
(CNS), including mood stability, pain tolerance, or sleep patterns. However, the vast majority …

Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases

A Quintero-Villegas, SI Valdés-Ferrer - Molecular Medicine, 2022 - Springer
HT7 receptors (5-HT7R) are the most recently identified among the family of serotonin
receptors. Their role in health and disease, particularly as mediators of, and druggable …

Quercetin conjugated with superparamagnetic iron oxide nanoparticles improves learning and memory better than free quercetin via interacting with proteins involved …

E Amanzadeh, A Esmaeili, REN Abadi… - Scientific reports, 2019 - nature.com
Biomedical application of quercetin (QT) as an effective flavonoid has limitations due to its
low bioavailability. Superparamagnetic iron oxide nanoparticle (SPION) is a novel drug …

Selective serotonin reuptake inhibitors and Alzheimer's disease

B Mdawar, E Ghossoub, R Khoury - Neural regeneration research, 2020 - journals.lww.com
Given the failure to develop disease-modifying therapies for Alzheimer's disease (AD),
strategies aiming at preventing or delaying the onset of the disease are being prioritized …

An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission

E Akyuz, A Arulsamy, FS Aslan, B Sarisözen… - Molecular …, 2024 - Springer
Alzheimer's disease (AD) is a progressive neurodegenerative disease. The accumulation of
amyloid-β (Aβ) plaques and tau neurofibrillary tangles are the key players responsible for …

Therapeutic potential and limitation of serotonin type 7 receptor modulation

K Fukuyama, E Motomura, M Okada - International Journal of Molecular …, 2023 - mdpi.com
Although a number of mood-stabilising atypical antipsychotics and antidepressants
modulate serotonin type 7 receptor (5-HT7), the detailed contributions of 5-HT7 function to …

Pharmacological Mechanisms Underlying the Neuroprotective Effects of Alpinia oxyphylla Miq. on Alzheimer's Disease

J Xu, F Wang, J Guo, C Xu, Y Cao, Z Fang… - International journal of …, 2020 - mdpi.com
Alpinia oxyphylla Miq.(ie, A. oxyphylla), a traditional Chinese medicine, can exert
neuroprotective effects in ameliorating mild cognitive impairment and improving the …

The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats

S Afshar, S Shahidi, AH Rohani, A Komaki, SS Asl - Psychopharmacology, 2018 - Springer
Rationale Alzheimer's disease (AD) is the most common form of dementia characterized by
a progressive decline in cognitive function. The serotonergic system via the 5-HT1A receptor …